Literature DB >> 16778588

Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: a single-blinded study.

Nicolaus Friedrichs1, Lydia Kriegl, Christopher Poremba, Karl-Ludwig Schaefer, Helmut Erich Gabbert, Akihiko Shimomura, Ellen Paggen, Sabine Merkelbach-Bruse, Reinhard Buettner.   

Abstract

The t(11;22) translocation is a diagnostic hallmark of various small round-cell tumors. This study correlates the performance of fluorescence in situ hybridization (FISH) and reverse transcription polymerase chain reaction (RT-PCR) in the detection of this translocation analyzing paraffin-embedded tissue specimens. As negative control samples, 10 cases of normal colon mucosa and 10 cases of colon carcinoma tissue were analyzed by FISH to determine a valid cutoff value for the diagnosis of a t(11;22) translocation. The mean number of false-positive nuclei differed significantly between disomic and polysomic control group cases (P=0.002). Therefore, the cutoff value was determined considering the pitfall polysomy. The analysis group consisted of 20 cases from the University of Düsseldorf and 10 cases from the University of Bonn. These cases were analyzed using PCR (Düsseldorf) and FISH (Bonn) using a single-blinded approach. Twenty-two cases (73.3%) were concordant in both methods. Five cases (16.7%) were discrepant, showing a positive result in FISH whereas PCR was negative. Three cases (10.0%) were analyzed by FISH, and PCR failed for nonoptimized tissue preparation. In conclusion, the detection of t(11;22) translocation is critically dependent on a thoroughly defined cutoff value for FISH and on appropriate tissue preparation for both methods. We recommend FISH as a sensitive screening tool in the detection of t(11;22) followed by subsequent PCR amplification of the specific chimeric transcript.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778588     DOI: 10.1097/00019606-200606000-00004

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  7 in total

1.  [Sarcomas: classification with morphologic and genetic criteria].

Authors:  H-U Schildhaus; R Büttner
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

Review 2.  [Molecular methods in the diagnosis of sarcoma].

Authors:  S Merkelbach-Bruse; E Wardelmann; H Künstlinger; R Büttner; H-U Schildhaus
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

Review 3.  [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].

Authors:  K Schmitz; H-U Schildhaus
Journal:  Pathologe       Date:  2015-03       Impact factor: 1.011

4.  AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report.

Authors:  Jan-Henrik Mikesch; Wolfgang Hartmann; Linus Angenendt; Otmar Huber; Christoph Schliemann; Maria Francisca Arteaga; Eva Wardelmann; Claudia Rudack; Wolfgang E Berdel; Markus Stenner; Inga Grünewald
Journal:  Cell Oncol (Dordr)       Date:  2018-06-05       Impact factor: 6.730

5.  Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression.

Authors:  I Alldinger; K L Schaefer; D Goedde; L Ottaviano; U Dirksen; A Ranft; H Juergens; H E Gabbert; W T Knoefel; C Poremba
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-25       Impact factor: 4.553

6.  Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.

Authors:  Inga Grünewald; Claudia Vollbrecht; Jeannine Meinrath; Moritz F Meyer; Lukas C Heukamp; Uta Drebber; Alexander Quaas; Dirk Beutner; Karl-Bernd Hüttenbrink; Eva Wardelmann; Wolfgang Hartmann; Reinhard Büttner; Margarete Odenthal; Markus Stenner
Journal:  Oncotarget       Date:  2015-07-20

7.  MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.

Authors:  Inga Grünewald; Marcel Trautmann; Alina Busch; Larissa Bauer; Sebastian Huss; Petra Schweinshaupt; Claudia Vollbrecht; Margarete Odenthal; Alexander Quaas; Reinhard Büttner; Moritz F Meyer; Dirk Beutner; Karl-Bernd Hüttenbrink; Eva Wardelmann; Markus Stenner; Wolfgang Hartmann
Journal:  Oncotarget       Date:  2016-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.